Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02530476
Title Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

myelodysplastic/myeloproliferative neoplasm

acute myeloid leukemia

bone marrow cancer

Therapies

Selinexor + Sorafenib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST